What is HOWL's dilution risk score?

HOWL has a latest available DilutionScore record of 50/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for HOWL, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for HOWL?

DilutionWatch tracks 25 SEC filing types for HOWL including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect HOWL shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For HOWL, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for HOWL tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for HOWL. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

HOWL Dilution Risk Score: 50/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

85

📊 Float Risk

10

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 45%

🔄 Reverse Split model est. 70%

• 50-day avg $0.74 below $1 exchange minimum

• Only 5 months cash — financial pressure

💰 Capital Raise model 35%

• Low cash runway: 5 months remaining

🔔 Track HOWL — Get forecast alerts →

Market Data

Market Cap$21.87M

Shares Outstanding48.60M

Float41.23M

Cash$21.99M

Debt$32.09M

Short InterestN/A

Institutional Holdings

QoQ: ↓ 6.1% shares (2026Q1 vs prior)

49 institutional holders · 15.57M shares

#1 RA CAPITAL MANAGEMENT, L.P. 6.68M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 2.44M shares

#3 MPM BIOIMPACT LLC 1.21M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.10M

Days to Cover1.3

% of Float2.7%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-12-31

8-K 8K EVENT 2026-08-21

4 INSIDER TRANSACTION 2026-07-08

SC 13D/A BENEFICIAL OWNERSHIP 2026-07-02

SC 13D/A BENEFICIAL OWNERSHIP 2026-06-26

Full SEC filing analysis available with free account →

Recent News

Werewolf Therapeutics shares surge 120% after Ambros merger and $150 million fin InvestorsHub · Aug 21

Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday MT Newswires · Aug 21

Werewolf Therapeutics to Merge With Ambros Therapeutics in All-Stock Deal MT Newswires · Aug 21

Factual HOWL Dilution Snapshot

Werewolf Therapeutics, Inc. (HOWL) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for HOWL: 8-K on 2026-08-21; 4 on 2026-07-08; SC 13D/A on 2026-07-02.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.